肺移植术中VA ECMO中心与外周动脉插管结局比较
本研究基于国际多中心ECLS肺移植登记数据,比较肺移植术中VA ECMO中心动脉插管与外周动脉插管患者的围术期结局。共纳入501例双肺移植,中心组315例、外周组186例。结果显示两组48-72小时PGD3发生率、移植相关结局、插管相关并发症及中期生存均无显著差异。
要点
- 中心与外周动脉插管组48-72小时PGD3发生率分别为26.3%与30.1%,无统计学差异。
- 动脉插管策略与PGD3风险、移植相关结局及插管相关并发症均无显著关联。
- 动脉插管部位选择应个体化,结合患者与手术需求决定。
核心结论
- 肺移植术中VA ECMO的动脉插管策略不影响PGD3风险、移植或插管相关并发症及中期生存。
研究设计与样本
- 多中心国际ECLS in LTx登记研究,分析2016年1月至2024年8月间使用术中VA ECMO的双肺移植,共501例(中心组315例,外周组186例)。
主要发现
- 48-72小时PGD3发生率中心组26.3%、外周组30.1%(p=0.42)。
- Logistic回归中中心vs外周插管与PGD3风险无关(OR 1.64,95%CI 0.657-4.209,p=0.294)。
- 两组其他移植相关结局及插管相关并发症(包括卒中)无差异。
- Cox回归中中心vs外周插管与总生存无关(HR 1.5,95%CI 0.70-3.20,p=0.298)。
临床怎么用
- 动脉插管部位选择应基于患者个体解剖与手术需求,而非为降低PGD3或并发症风险而常规偏好某一部位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative venoarterial extracorporeal membrane oxygenation (VA ECMO) is becoming the most common mode of extracorporeal life support (ECLS) in lung transplantation (LTx). We compared rates of primary graft dysfunction (PGD) and other perioperative outcomes in patients who underwent LTx using VA ECMO with either central or peripheral arterial cannulation. METHODS: We analyzed bilateral lung transplants using intraoperative VA ECMO which were entered into the multicenter international ECLS in LTx registry between 1/2016 and 8/2024. Our primary outcome included Grade 3 Primary Graft Dysfunction (PGD3) at 48-72 hours. Secondary outcomes included postoperative complications and survival. RESULTS: There were 501 transplants that met inclusion criteria: 315 in the central group and 186 in the peripheral group. The incidence of PGD3 at 48-72 hours was 26.3% in the central group and 30.1% in the peripheral group (p = 0.42). In the logistic regression analysis, central vs peripheral cannulation was not associated with increased risk of PGD3 (OR 1.64, 95% CI 0.657-4.209, p = 0.294). We found no difference between groups in other graft-related outcomes nor cannulation-related complications including stroke. In the Cox regression analysis, central vs peripheral cannulation was not associated with overall survival (HR 1.5, 95% CI 0.70-3.20, p = 0.298). CONCLUSIONS: The choice of arterial cannulation strategy for intraoperative VA ECMO support did not impact the risk of PGD3, graft- or cannulation-related complications, nor mid-term survival. The decision regarding arterial cannulation site strategy should be tailored to meet patient and procedural needs.
引用
- Fernandez R, Ius F, Reyes JEM, et al. Outcomes of central versus peripheral arterial cannulation for intraoperative extracorporeal membrane oxygenation support in lung transplantation. J Heart Lung Transplant. 2025. PMID: 41072743. doi:10.1016/j.healun.2025.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。